Literature DB >> 15170910

What I would like to know about leflunomide.

Joel M Kremer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15170910

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  Leflunomide and methotrexate combination therapy in daily clinical practice.

Authors:  A Dendooven; L De Rycke; X Verhelst; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2006-06       Impact factor: 19.103

2.  Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Brian C Sauer; Grant W Cannon; Chia-Chen Teng; Kaleb Michaud; Said Ibrahim; Erik Jorgenson; Lisa Davis; Liron Caplan; Amy Cannella; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

3.  3D-QSAR studies on a series of dihydroorotate dehydrogenase inhibitors: analogues of the active metabolite of leflunomide.

Authors:  Shun-Lai Li; Mao-Yu He; Hong-Guang Du
Journal:  Int J Mol Sci       Date:  2011-05-10       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.